GL1X · GenesisL1 explorer

Research workbench

Crystal structure of the Fab domain of omalizumab at 2.41A

Analyse Crystal structure of the Fab domain of omalizumab at 2.41A in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
2XA8
Type
protein
Length
437 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Omalizumab heavy chain; Omalizumab light chain
Pockets
1 · best druggability 0.61

Structure

x-ray diffraction · 2 distinct chains · 7% helix, 51% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
HOmalizumab heavy chainprotein2198% helix, 49% strand—
LOmalizumab light chainprotein2186% helix, 53% strand—

Pockets

1 pocket found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
15160.610.7551empty

Interfaces

1 interface between chains.

  • H–L · 1975 Ų buried · 22 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 4 disulfide (disulfide).

Compared structures

  • 2XA8 · Crystal structure of the Fab domain of omalizumab at 2.41A · the same entry in another collection · chain H against H, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.